Probiotics as a therapeutic alternative in amoebiasis. Where are we?
DOI:
https://doi.org/10.33448/rsd-v13i10.47039Keywords:
Entamoeba histolytica, Probiotics, Protozoa.Abstract
Entamoeba histolytica is the cause of amoebiasis, a neglected tropical disease and a leading cause of mortality worldwide. The objective of this review is to show the potential of probiotics as a treatment strategy for amoebiasis. A systematic search was conducted using PubMed and Google Scholar with keywords "Entamoeba histolytica", "amoebiasis", and "probiotics." The studies on probiotics for amoebiasis treatment are limited, but some shown promising results. Lactobacillus acidophilus reduced E. histolytica cyst excretion by 79.67% in mice, with a 68.31% efficacy comparable to metronidazole. Bifidobacterium sp. showed 75.63% efficacy in reducing infection severity, higher than metronidazole (67.56%). Lactobacillus salivarius inhibited E. histolytica growth in vitro and provided protection in vivo. Lactobacillus fermentum and L. delbrueckii inhibited E. histolytica proliferation with efficacy ranging from 46.42% to 97.68%, depending on the concentration. Saccharomyces boulardii reduced amoebic dysentery duration by 25% and eliminated parasitic cysts in human stool samples. Lactobacillus casei showed a 100% recovery rate in rats infected with E. histolytica. These findings suggest probiotics have potential as therapeutic agents for amoebiasis, but further research is needed to confirm their effectiveness in animal models and humans.
Downloads
References
Abasszade, J. H., Little, R., Yeaman, F., Robertson, M., & Bell, S. (2021). Amoebic colitis: A case series of a recurring missed diagnosis. JGH Open, 5(3), 404-407.
Adl, S. M., Bass, D., Lane, C. E. et al. (2019). Revisions to the classification, nomenclature, and diversity of eukaryotes. Journal of Eukaryotic Microbiology, 66(1), 4-119.
Al-Tawaha, R., & Meng, C. (2018). Potential benefits of Lactobacillus plantarum as probiotic and its advantages in human health and industrial applications: A review. Adv. Environ. Biol, 12, 16-27.
Birchenough, G. M., Johansson, M. E., Gustafsson, J. K., Bergström, J. H., & Hansson, G. (2015). New developments in goblet cell mucus secretion and function. Mucosal immunology, 8(4), 712-719.
Carrero, J. C., Reyes-López, M., Serrano-Luna, J., Shibayama, M., Unzueta, J., León-Sicairos, N., & de la Garza, M. (2020). Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries. International Journal of Medical Microbiology, 310(1), 151358.
Cuellar-Guevara, F. L., Barrón-González, M. P., & Menchaca-Arredondo, J. L. (2019). Effect of Lactobacillus postbiotics on Entamoeba histolytica trophozoites. Revista de investigación clínica, 71(6), 402-407.
Das, M., Biswas, P., & Dam, S. (2024). Isolation and Potential Probiotic Characterization of Lactic Acid Bacteria from an Ethnic Fermented Beverage having Antibacterial Activity against Human Pathogen Entamoeba histolytica. International Journal of Pharmaceutical Investigation, 14(2).
Dinleyici, E., Eren, M., Yargic, Z., DOĞAN, N., & Vandenplas, Y. (2009). Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: a prospective, randomized, open label study. American Journal of Tropical Medicine and Hygiene, 80(6).
Flach, J., Van Der Waal, M. B., Kardinaal, A. F. M., Schloesser, J., Ruijschop, R. M. A. J., & Claassen, E. (2018). Probiotic research priorities for the healthy adult population: A review on the health benefits of Lactobacillus rhamnosus GG and Bifidobacterium animalis subspecies lactis BB-12. Cogent Food & Agriculture, 4(1), 1452839.
Gomes, I. S. & Caminha, I. O. (2014). Guia para estudos de revisão sistemática: uma opção metodológica para as Ciências do Movimento Humano. Movimento. 20 (1), 395-411.
Guillén, N. (2023). Pathogenicity and virulence of Entamoeba histolytica, the agent of amoebiasis. Virulence, 14(1), 2158656.
Imperato, P. J. (1981). A historical overview of amebiasis. Bulletin of the New York Academy of Medicine, 57(3), 175.
Johansson, M. E., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proceedings of the national academy of sciences, 105(39), 15064-15069.
Khalaf, K. J. (2013). Study of Lactobacillus acidophilus as atreatment and prophylaxis for Entamoeba histolytica infected mice. World Journal of Pharmaceutical Research, 2(5), 1229-1237.
Kissoon-Singh, V., Moreau, F., Trusevych, E., & Chadee, K. (2013). Entamoeba histolytica exacerbates epithelial tight junction permeability and proinflammatory responses in Muc2−/− mice. The American journal of pathology, 182(3), 852-865.
Lidell, M. E., Moncada, D. M., Chadee, K., & Hansson, G. C. (2006). Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. Proceedings of the National Academy of Sciences, 103(24), 9298-9303.
Magistrelli, L., Amoruso, A., Mogna, L., Graziano, T., Cantello, R., Pane, M., & Comi, C. (2019). Probiotics may have beneficial effects in Parkinson's disease: in vitro evidence. Frontiers in immunology, 10, 969.
Maldonado Galdeano, C., Cazorla, S. I., Lemme Dumit, J. M., Vélez, E., & Perdigón, G. (2019). Beneficial effects of probiotic consumption on the immune system. Annals of Nutrition and Metabolism, 74(2), 115-124.
Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K., & Shafaghi, A. (2003). Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World journal of gastroenterology: WJG, 9(8), 1832.
Mattos, P. C. (2015). Tipos de revisão de literatura. Unesp, 1-9. https://www.fca.unesp.br/Home/Biblioteca/tipos-de-evisao-de-literatura.pdf 6.1.3).
Mazziotta, C., Tognon, M., Martini, F., Torreggiani, E., & Rotondo, J. C. (2023). Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells, 12(1), 184.
Mohamed, S. T. (2014). Use of Bifidobacterium for Treatment and Protective from Entamoeba Histolytica Infection in Mice. International Journal of Science and Technology, 3(1).
Mohammed, S., Khalaf, K., & Sulaiman, N. (2015). Lactobacillus salivarius bacteriocin and supernatant activity against Entamoeba histolytica in vitro and in vivo. Br J Biol Health Med Sci Res, 3, 19-28.
Moncada, D., Keller, K., & Chadee, K. (2005). Entamoeba histolytica-secreted products degrade colonic mucin oligosaccharides. Infection and immunity, 73(6), 3790-3793.
Montalban-Arques, A., De Schryver, P., Bossier, P., Gorkiewicz, G., Mulero, V., Gatlin III, D. M., & Galindo-Villegas, J. (2015). Selective manipulation of the gut microbiota improves immune status in vertebrates. Frontiers in Immunology, 6, 512.
Morán, P., Serrano-Vázquez, A., Rojas-Velázquez, L., González, E., Pérez-Juárez, H., Hernández, E. G., ... & Ximénez, C. (2023). Amoebiasis: Advances in diagnosis, treatment, immunology features and the interaction with the intestinal ecosystem. International Journal of Molecular Sciences, 24(14), 11755.
Pelaseyed, T., Bergström, J. H., Gustafsson, J. K., Ermund, A., Birchenough, G. M., Schütte, A., ... & Hansson, G. C. (2014). The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunological reviews, 260(1), 8-20.
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM. 6.1.2).
Rahi, A. A., & Nashaat, Z. (2013). Leaky cells and the use of Lactobacillus casei in the treatment of laboratory animals infected with amoebic dysentery. Euphrates Journal of Agriculture Science, 5(1), 15-22.
Sabti, Z. S., Abbas, S. K., & Mahmood, N. N. (2019). Investigation the Role of Lactobacillus ssp. on Entamoeba histolytica Pathogenesis. Indian Journal of Public Health Research & Development, 10(10).
Samba-Louaka, A., Delafont, V., Rodier, M. H., Cateau, E., & Héchard, Y. (2019). Free-living amoebae and squatters in the wild: ecological and molecular features. FEMS microbiology reviews, 43(4), 415-434.
Sanders, M. E., Guarner, F., Guerrant, R., Holt, P. R., Quigley, E. M., Sartor, R. B., ... & Mayer, E. A. (2013). An update on the use and investigation of probiotics in health and disease. Gut, 62(5), 787-796.
Sarao, L. K., & Arora, M. (2017). Probiotics, prebiotics, and microencapsulation: A review. Critical reviews in food science and nutrition, 57(2), 344-371.
Sarid, L., Zanditenas, E., Ye, J., Trebicz-Geffen, M., & Ankri, S. (2022). Insights into the mechanisms of Lactobacillus acidophilus activity against Entamoeba histolytica by using thiol redox proteomics. Antioxidants, 11(5), 814.
Savaş-Erdeve, S., Gökay, S., & Dallar, Y. (2009). Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children. The Turkish Journal of Pediatrics, 51(3), 220-224.
Shafeek, Z., & Ruzzuki, N. (2016). The effect of different concentrations of the run and stuck bacteria (Lactobacillus fermentum, Lactobacillus delbrueckii) in trophozoite growth of Entamoeba histolytica in vitro. Int J Curr Microbiol Appl Sci, 5, 924-30.
Sperandio, B., Fischer, N., & Sansonetti, P. J. (2015). Mucosal physical and chemical innate barriers: Lessons from microbial evasion strategies. In Seminars in immunology, Vol. 27, No. 2, pp. 111-118.
Uribe-Querol, E., & Rosales, C. (2020). Immune response to the enteric parasite Entamoeba histolytica. Physiology, 35(4), 244-260.
Walsh, J. A. (1986). Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Reviews of infectious diseases, 8(2), 228-238.
Whittemore, R., & Knafl, K. (2005). The integrative review: updated methodology. Journal of advanced nursing, 52(5), 546-553.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Vivian Moura de Oliveira; Matheus Rezende Corrêa; Isabela Cristina Vieira Silva; Larissa Rezende Corrêa; Maria Aparecida Gomes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
